Cyclodextrins (CDs), a class of cyclic oligosaccharides that were "born" in 1891, have opened up endless research and commercial opportunities in numerous fields that span carbohydrate, supramolecular (host-guest) and analytical chemistry all the way from research laboratories in academia to the mass production of products—e.g., skin care enablers to drug delivery systems—in industry.
